Personal profile
Research Interests
teaching
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics where Yvonne Akotoa Dei-Adomakoh is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Advancing Sickle Cell Disease Treatment in Sub-Saharan Africa: Challenges and Opportunities for Disease Modifying Therapies
Dei-Adomakoh, Y., Ambrose, E. E. & Power-Hays, A., Apr 2026, In: American Journal of Hematology. 101, S1, p. 33-46 14 p.Research output: Contribution to journal › Review article › peer-review
1 Citation (Scopus) -
A Multidimensional Digital Approach to Pain Assessment in Sickle Cell Disease: A Feasibility Study in Ghana
Obasohan, M. E., Asare, E. V., Jonassaint, C., Owusu-Ansah, A. T., Segbefia, C., Mamauag, E., Dei-Adomakoh, Y., Hillery, C. A. & Oluwole, O., 2026, In: Journal of Pain Research. 19, 548824.Research output: Contribution to journal › Article › peer-review
Open Access -
The West African Genetic Medicine Center as a model to address the challenge of genetic disorders in Africa
Ofori-Acquah, S. F., Nuno, M., Osae-Larbi, J. A., Tavares, K., Osei-Tutu, A., Barkers Ansah, D. A., Brobbey, E. Y., Akuffo, F., Honny, J., Buertey, I., Dei-Adomakoh, Y., Renner, L., Paemka, L., Benneh-Akwasi Kuma, A., Kudzi, W. & Anie, K. A., Mar 2026, In: Nature Genetics. 58, 3, p. 467-471 5 p.Research output: Contribution to journal › Comment/debate
-
African solutions for African medical education: the strategic establishment of the Consortium of Medical Schools in Africa
CoMSA Members, 17 Aug 2025, In: BMJ Global Health. 10, 8, e020145.Research output: Contribution to journal › Comment/debate
Open Access1 Citation (Scopus) -
Crizanlizumab with or without hydroxyurea in patients with sickle cell disease (STAND): primary analyses from a placebo-controlled, randomised, double-blind, phase 3 trial
Abboud, M. R., Cançado, R. D., De Montalembert, M., Smith, W. R., Rimawi, H., Voskaridou, E., Güvenç, B., Ataga, K. I., Keefe, D., Grosch, K., Watson, J., Reshetnyak, E., Nassin, M. L. & Dei-Adomakoh, Y., Apr 2025, In: The Lancet Haematology. 12, 4, p. e248-e257Research output: Contribution to journal › Article › peer-review
15 Citations (Scopus)